Clinical Outcomes in Patients with Renal Cell Carcinoma Metastases to the Choroid Plexus

被引:8
|
作者
Crisman, Celina M. [1 ]
Patel, Ankur R. [2 ,3 ]
Winston, Graham [4 ]
Brennan, Cameron W. [2 ,3 ]
Tabar, Viviane [2 ,3 ]
Moss, Nelson S. [2 ,3 ]
机构
[1] UMass Mem Med Ctr, Dept Neurosurg, Worcester, MA USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Brain Metastasis Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, New York, NY USA
基金
美国国家卫生研究院;
关键词
Choroid plexus; Intraventricular metastasis; Renal cell carcinoma; Stereotactic body radiotherapy; Stereotactic radiosurgery; BRAIN METASTASES; PROGNOSTIC-FACTORS; SURVIVAL; RADIOSURGERY; THERAPY;
D O I
10.1016/j.wneu.2020.03.125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Intraventricular metastatic brain tumors account for a small, but challenging, fraction of metastatic brain tumors (0.9%-4.5%). Metastases from renal cell carcinoma (RCC) account for a large portion of these intraventricular tumors. Although patient outcomes have been assumed to be poor, these have not been reported in a modern series with a multimodality treatment paradigm of radiotherapy (RT), resection, and cerebrospinal fluid (CSF) diversion. We have presented the first case series of patients with intraventricular metastatic tumors from RCC. METHODS: We performed a single-institution retrospective review of patients with intraventricular RCC metastases treated from January 2003 to January 2019. Volumetric analysis was used to delineate the tumor size and the Kaplan-Meier method to evaluate the survival data. RESULTS: A total of 22 intraventricular RCC metastases were identified in 19 patients with 61.3 patient-years of follow-up. The median patient age was 64 years, and the median tumor volume was 2.2 cm(3). Overall, 19 metastases had been treated initially with RT. Of these, 16 had received stereotactic body RT and 3 had received whole brain RT. Three tumors were surgically excised and had received adjuvant stereotactic body RT in the upfront setting. Although 5 patients had presented with obstructive hydrocephalus, none had required CSF diversion. After treatment, 5 metastases had progressed, resulting in 1- and 3-year progression-free survival rates of 81.6% and 68%, respectively. The median overall survival was 2.8 years, with 1- and 5-year overall survival rates of 76.7% and 28.3%, respectively. Leptomeningeal carcinomatosis was not observed. CONCLUSIONS: Despite the relatively limited overall survival for this population with metastatic cancer, comparable to contemporary parenchymal brain metastasis cohorts, reasonable local central nervous system control was achieved in most patients using a paradigm of focal RT and resection, where indicated. Finally, CSF diversion was not required even in patients presenting with hydrocephalus.
引用
收藏
页码:E7 / E13
页数:7
相关论文
共 50 条
  • [21] Clinical predictive factor of metastases in renal cell carcinoma
    Widia, F.
    Hamid, A. R. A. H.
    Mochtar, C. A.
    Umbas, R.
    BJU INTERNATIONAL, 2016, 117 : 9 - 10
  • [22] Survival of patients with choroid plexus carcinoma improves with chemotherapy
    Wrede, B.
    Kutluk, T.
    Wolff, J.
    NEURO-ONCOLOGY, 2007, 9 (02) : 216 - 217
  • [23] Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases.
    Dogan, Izzet
    Iribas, Ayca
    Paksoy, Nail
    Ekenel, Meltem
    Vatansever, Sezai
    Basaran, Mert
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [24] Treatment outcomes in renal cell carcinoma patients with metastases to the pancreas and other sites.
    Duarte, Cassandra
    Beuselinck, Benoit
    Weise, Nicole
    Dizman, Nazli
    Collier, Katharine
    Li, Haoran
    Chanza, Nieves Martinez
    Elias, Roy
    Rose, Tracy L.
    Brugarolas, James
    Agarwal, Neeraj
    Mortazavi, Amir
    Pal, Sumanta K.
    McKay, Rana R.
    Hu, Junxiao
    Lam, Elaine Tat
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era
    Kalra, Sarathi
    Verma, Jonathan
    Atkinson, Bradley J.
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Lin, Sue-Hwa
    Satcher, Robert L.
    Tamboli, Pheroze
    Sircar, Kanishka
    Rao, Priya
    Corn, Paul G.
    Tannir, Nizar M.
    Jonasch, Eric
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : 363 - 370
  • [26] Choroid plexus carcinoma in a cow
    Ferreira de Sant'Ana, Fabiano Jose
    Gabriel, Adriane Loy
    Kommers, Glaucia Denise
    Lombardo de Barros, Claudio Severo
    CIENCIA RURAL, 2009, 39 (07): : 2229 - 2232
  • [27] Choroid plexus carcinoma in a goat
    Klopfleisch, R.
    Beier, D.
    Teifke, J. P.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2006, 135 (01) : 42 - 46
  • [28] Chemotherapy of choroid plexus carcinoma
    Greenberg, ML
    CHILDS NERVOUS SYSTEM, 1999, 15 (10) : 571 - 577
  • [29] Choroid plexus carcinoma in an adult
    Kishore, Sanjeev
    Negi, Gita
    Meena, Harsh
    Anuradha, Kusum
    Pathak, Prakash Ved
    Bansal, K. K.
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2012, 3 (01) : 71 - 73
  • [30] Chemotherapy of choroid plexus carcinoma
    Mark L. Greenberg
    Child's Nervous System, 1999, 15 : 571 - 577